Iterum Therapeutics plc
USD0.03
-0.00 (-10.98%)
CEO
Corey N. Fishman
IPO Date
2018-05-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
IE
Open
$0.04
Prev. Close
$0.03
Day Low
$0.03
Day High
$0.05
52W Low
$0.03
52W High
$1.42
Market Cap
$0.00B
Volume
49.30M
| 15,000 |
| $0.72 |
| 3 Jul 2025 | Coyne Christine | Chief Commercial Officer | A-Award | Acquired | 200,000 | $0.97 |
| 3 Jul 2025 | Coyne Christine | — | Disposed | 0 | $0.00 |
| 23 Jan 2025 | HUNT RONALD | director | J-Other | Disposed | 0 | $0.00 |
| 12 Aug 2024 | Dunne Michael W. | director | M-Exempt | Acquired | 106,247 | $1.21 |
| 12 Aug 2024 | Dunne Michael W. | director | M-Exempt | Acquired | 106,247 | $1.21 |
| 12 Aug 2024 | Dunne Michael W. | director | M-Exempt | Disposed | 212,494 | $0.61 |
| 12 Aug 2024 | Fishman Corey N. | director, officer: Chief Executive Officer | M-Exempt | Acquired | 82,613 | $1.21 |
| 12 Aug 2024 | Fishman Corey N. | director, officer: Chief Executive Officer | M-Exempt | Acquired | 82,613 | $1.21 |